Contraindicated in persistently severe bradycardia, second- and third-degree heart
block, overt cardiac failure, and cardiogenic shock.
Cutaneous side effects of beta-receptor blockers are clinically polymorphous. They apparently appear after several months of continuous therapy.
- TRADE NAME: Sectral (Sanofi-Aventis)
- INDICATIONS: Hypertension, angina, ventricular arrhythmias
- CLASS: Antiarrhythmic class II, Beta adrenergic blocker, Beta-blocker
- HALF-LIFE: 3–7 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Adrenergic neurone blockers, Alcohol, Aldesleukin, Alpha blockers, Alprostadil, Amiodarone, Angiotensin II receptor antagonists, Antiarrhythmics, Antidiabetics, Anxiolytics and hypnotics, Baclofen, Calcium channel blockers, Cardiac glycosides, Clonidine, Corticosteroids, Diazoxide, Diltiazem, Disopyramide, Diuretics, Ergotamine, Estrogens, Flecainide, General anesthetics, Hydralazine, Insulin, Levodopa, MAO inhibitors, Mefloquine, Methyldopa, Methysergide, Minoxidil, Moxisylyte, Moxonidine, Nifedipine, Nitrates, Nitroprusside, NSAIDs, Phenothiazines, Pilocarpine, Prazosin, Tizanidine, Verapamil
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
